Flax oil-mediated activation of PPAR-correlates with reduction of hepatic lipid accumulation in obese spontaneously hypertensive/NDmcr-cp rats, a model of the metabolic syndrome

British Journal of Nutrition

Volumn 104, Issue 9, 2010, Pages 1313-1321

  Chechi, Kanta ^a,b   Yasui, Naomi ^a   Ikeda, Katsumi ^a   Yamori, Yukio ^a   Cheema, Sukhinder K ^b  

^a MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Flax oil; Hepatic lipids; Obese spontaneously hypertensive NDmcr cp rats; PPAR expression

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; INSULIN; LARD; LINSEED OIL; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; ANTILIPEMIC AGENT; VEGETABLE OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORRELATION ANALYSIS; EPIDIDYMIS FAT; FATTY LIVER; GENE EXPRESSION; GENETIC MODEL; HYPERGLYCEMIA; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIVER WEIGHT; METABOLIC SYNDROME X; NONHUMAN; OBESE SPONTANEOUSLY HYPERTENSIVE/NDMCR-CP RAT; OXIDATIVE STRESS; RAT; RAT STRAIN; ANIMAL; BLOOD; CHEMISTRY; DISEASE MODEL; FAT INTAKE; FLAX; GENETICS; LIVER; METABOLISM; OBESITY; PHYTOTHERAPY; SPONTANEOUSLY HYPERTENSIVE RAT;

LINUM USITATISSIMUM; RATTUS;

ANIMALS; ANTILIPEMIC AGENTS; DIETARY FATS; DISEASE MODELS, ANIMAL; FLAX; INSULIN; LIPID METABOLISM; LIVER; METABOLIC SYNDROME X; OBESITY; PHYTOTHERAPY; PLANT OILS; PPAR GAMMA; RATS; RATS, INBRED SHR; RNA, MESSENGER; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 78149478036     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114510002187     Document Type: Article

References (49)

1. Bricker L & Greydanus D (2008) The metabolic syndrome: a gathering challenge in a time of abundance. Adolesc Med State Art Rev 19, 475-497.
2. Renaud S & de Lorgeril M (1989) Dietary lipids and their relationship to ischemic heart disease: from epidemiology to prevention. J Intern Med 225, 1-8.
3. Artaud-Wild S, Connor S, Sexton G, et al. (1993) Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox. Circulation 88, 2771-2779.
4. Keys A (1997) Coronary heart disease in seven countries 1970. Nutrition 13, 250-252.
5. Denke MA (2006) Dietary fats, fatty acids, and their effects on lipoproteins. Curr Atheroscler Rep 8, 466-471.
6. Dolecek T (1992) Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial. Proc Soc Exp Biol Med 200, 177-182.
7. Demaison L & Moreau D (2002) Dietary n-3 polyunsaturated fatty acids and coronary heart disease-related mortality: a possible mechanism of action. Cell Mol Life Sci 59, 463-477.
8. Vemuri M, Kelley DS, Mackey BE, et al. (2007) Docosahexaenoic acid (DHA) but not eicosapentaenoic acid (EPA) prevents trans-10, cis-12 conjugated linoleic acid (CLA)-induced insulin resistance in mice. Metab Syndr Relat Disord 5, 315-322.
9. Davis B & Kris-Etherton P (2003) Achieving optimal essential fatty acids status in vegetarians: current knowledge and practical implications. Am J Clin Nutr 78, 640S-646S.
10. Kelley D, Branch D & Love J (1991) Dietary ALA and immunocompetence humans. Am J Clin Nutr 53, 40-46.
11. Mantzioris E, James M, Gibson R, et al. (1994) Dietary substitution with an ALA rich vegetable oil increases EPA concentrations in tissues. Am J Clin Nutr 59, 1304-1307.
12. Cunnane S, Gangali S, Menard A, et al. (1993) High alphalinolenic acid flaxseed (Linum usitatissimum). Some nutritional properties in humans. Br J Nutr 69, 443-453.
13. Craig W (1999) Health-promoting properties of common herbs. Am J Clin Nutr 70, 491-499.
14. Murase T, Aoki M & Tokimitsu I (2005) Supplementation with alpha-linolenic acid-rich diacylglycerol suppresses fatty liver formation accompanied by an up-regulation of beta-oxidation in zucker fatty rats. Biochim Biophys Acta 1733, 224-231.
15. Cohen SL, Moore AM & Ward WE (2005) Flaxseed oil and inflammation-associated bone abnormalities in interleukin-10 knockout mice. J Nutr Biochem 16, 368-374.
16. Junko Y, Ikeda K & Yamori Y (2005) Obese and hypertensive SHR/NDmcr-cp rats - a model of metabolic syndrome. Adiposcience 2, 243-248.
17. Yasui N, Hiraoka-Yamamoto J, Kitamori K, et al. (2007) Effects of dietary fibre on SHR/NDmcr-cp (fak/fak) rat, a model of metabolic syndrome. Clin Exp Pharmacol Physiol 34, S43-S44.
18. Yamaguchi Y, Yamada K, Yoshikawa N, et al. (2006) Corosolic acid prevents oxidative stress, inflammation and hypertension in SHR/NDmcr-cp rats, a model of metabolic syndrome. Life Sci 79, 2474-2479.
19. Keough KM & Davis PJ (1979) Gel to liquid-crystalline phase transitions in water dispersions of saturated mixed-acid phosphatidylcholines. Biochemistry 18, 1453-1459.
20. Usui S, Hara Y, Hosaki S, et al. (2002) A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. J Lipid Res 43, 805-814.
21. Folch J, Lees M & Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497-509.
22. Chan J, Bruce V & McDonald B (1991) Dietary alpha linolenic acid is as effective as oleic acid and linolenic acid in lowering blood cholesterol in normolipidemic men. J Am Coll Nutr 53, 1230-1235.
23. Ghafoorunissa, Ibrahim A & Natarajan S (2005) Substituting dietary linoleic acid with alpha-linolenic acid improves insulin sensitivity in sucrose fed rats. Biochim Biophys Acta 1733, 67-75.
24. Kotronen A, Westerbacka J, Bergholm R, et al. (2007) Liver fat in the metabolic syndrome. J Clin Endocrinol Metab 92, 3490-3497.
25. Gan SK, Adams LA & Watts GF (2008) The trials and tribulations of the treatment of nonalcoholic fatty-liver disease. Curr Opin Lipidol 19, 592-599.
26. Chitturi S, Abeygunasekera S, Farrell G, et al. (2002) NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35, 373-379.
27. Browning J & Horton J (2004) Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114, 147-152.
28. Ozcan U, Cao Q, Yilmaz E, et al. (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306, 457-461.
29. Morise A, Mourot J, Riottot M, et al. (2005) Dose effect of alpha-linolenic acid on lipid metabolism in the hamster. Reprod Nutr Dev 45, 405-418.
30. Morise A, Mourot J, Boué C, et al. (2006) Gender-related response of lipid metabolism to dietary fatty acids in the hamster. Br J Nutr 95, 709-720.
31. Vijaimohan K, Jainu M, Sabitha KE, et al. (2006) Beneficial effects of alpha linolenic acid rich flaxseed oil on growth performance and hepatic cholesterol metabolism in high fat diet fed rats. Life Sci 79, 448-454.
32. Ide T, Kobayashi H, Ashakumary L, et al. (2000) Comparative effects of perilla and fish oils on the activity and gene expression of fatty acid oxidation enzymes in rat liver. Biochim Biophys Acta 1485, 23-35.
33. Osborne TF (2000) Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. J Biol Chem 275, 32379-32382.
34. Fukumitsu S, Aida K, Ueno N, et al. (2008) Flaxseed lignan attenuates high-fat diet-induced fat accumulation and induces adiponectin expression in mice. Br J Nutr 100, 669-676.
35. Braissant O, Foufelle F, Scotto C, et al. (1996) Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, beta, and -gamma in the adult rat. Endocrinology 137, 354-366.
36. Shalev A, Siegrist-Kaiser C, Yen P, et al. (1996) The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin. Endocrinology 137, 4499-4502.
37. Vidal-Puig A, Jimenez-Liñan M, Lowell B, et al. (1996) Regulation of PPAR-gamma gene expression by nutrition and obesity in rodents. J Clin Invest 97, 2553-2561.
38. Burant C, Sreenan S, Hirano K, et al. (1997) Troglitazone action is independent of adipose tissue. J Clin Invest 100, 2900-2908.
39. Edvardsson U, Bergstrom M, Alexandersson M, et al. (1999) Rosiglitazone (BRL49653), a PPAR gamma-selective agonist, causes peroxisome proliferator-like liver effects in obese mice. J Lipid Res 40, 1177-1184.
40. Bedoucha M, Atzpodien E & Boelsterli UA (2001) Diabetic KKAy mice exhibit increased hepatic PPARgamma1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones. J Hepatol 35, 17-23.
41. Rahimian R, MasihKhan E, Lo M, et al. (2001) Hepatic overexpression of peroxisome proliferator activated receptor gamma-2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus. Mol Cell Biochem 224, 29-37.
42. Memon RA, Tecott LH, Nonogaki K, et al. (2000) Upregulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinology 141, 4021-4031.
43. Yan W, Dou J, Pan C, et al. (2008) Candesartan improves insulin resistance induced by high-fat diet in rats. Zhonghua Yi Xue Za Zhi 88, 2695-2699.
44. Kelley DS, Vemuri M, Adkins Y, et al. (2009) Flaxseed oil prevents trans-10, cis-12-conjugated linoleic acid-induced insulin resistance in mice. Br J Nutr 101, 701-708.
45. Schwab US, Callaway JC, Erkkilä AT, et al. (2006) Effects of hempseed and flaxseed oils on the profile of serum lipids, serum total and lipoprotein lipid concentrations and haemostatic factors. Eur J Nutr 45, 470-477.
46. Kaul N, Kreml R, Austria JA, et al. (2008) A comparison of fish oil, flaxseed oil and hempseed oil supplementation on selected parameters of cardiovascular health in healthy volunteers. J Am Coll Nutr 27, 51-58.
47. Lee P & Prasad K (2003) Effects of flaxseed oil on serum lipids and atherosclerosis in hypercholesterolemic rabbits. J Cardiovasc Pharmacol Ther 8, 227-235.
48. Edralin AL, Robert DW, Lisa JH, et al. (2002) Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab 87, 1527-1532.
49. Felmlee MA, Woo G, Simko E, et al. (2009) Effects of the flaxseed lignans secoisolariciresinol diglucoside and its aglycone on serum and hepatic lipids in hyperlipidaemic rats. Br J Nutr 102, 361-369.